SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren's disease.
- DOI
- 10.1016/j.trsl.2026.09.015
- Published
- 2026 Sep 23
- Container
- Translational research : the journal of laboratory and clinical medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.trsl.2026.09.015,
title = {SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren's disease.},
author = {Xuan Y and Cheng D and Xi Q and Sun L and Li N and Lei X and Yang M and Liu H and Li L and Hu W and Wu H},
year = {2026},
journal = {Translational research : the journal of laboratory and clinical medicine},
doi = {10.1016/j.trsl.2026.09.015},
url = {https://doi.org/10.1016/j.trsl.2026.09.015}
}RIS
TY - JOUR TI - SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren's disease. AU - Xuan Y AU - Cheng D AU - Xi Q AU - Sun L AU - Li N AU - Lei X AU - Yang M AU - Liu H AU - Li L AU - Hu W AU - Wu H PY - 2026 JO - Translational research : the journal of laboratory and clinical medicine DO - 10.1016/j.trsl.2026.09.015 UR - https://doi.org/10.1016/j.trsl.2026.09.015 ER -
APA
Y, X., D, C., Q, X., L, S., N, L., X, L., M, Y., H, L., L, L., W, H., & H, W. (2026). SIRT1-mediated deacetylation of TRIM21 promotes IRF5 degradation and restrains type I interferon signatures in Sjögren's disease.. Translational research : the journal of laboratory and clinical medicine. https://doi.org/10.1016/j.trsl.2026.09.015
Source records
- pubmed · retrieved 2026-09-26T02:03:06.492Z